(Total Views: 101)
Posted On: 06/11/2021 1:15:51 PM
Post# of 85302
$FBIO News Article - Mustang Bio Announces Updated Interim Phase 1/2 Data for MB-106 CD20-Targeted CAR T in Patients with Relapsed or Refractory B-cell Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia https://marketwirenews.com/news-releases/must...54410.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
